BCDA BIOCARDIA INC
FollowCOM NEW (common), issuer CIK 925741
Filings received so far for Q3 2026: 21 13F filers report a position in BCDA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- SATTERFIELD THOMAS A JR
1,539,134 shares, 9.9% in a 13G/A as of 2026-09-30,0001104659-26-125056
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Altman Peterdirector, officer (President and CEO) | 2026-10-16 | +300 P | $0.95 | Form 4 |
| Altman Peterdirector, officer (President and CEO) | 2026-10-15 | +200 P | $0.95 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
SATTERFIELD THOMAS A JR reported 1,539,134 BCDA shares, 9.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-10. 0001104659-26-125056
Accepted , ingestedAltman Peter bought 500 BCDA shares between 2026-10-15 and 2026-10-16, Form 4 filed 2026-10-20. 0001437749-26-033030
Accepted , ingested